Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| (NASDAQ: CGNT) | Delayed: 9.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.33 | 52 Week High | $2.48 | |||
| Open | $9.33 | 52 Week Low | $0.71 | |||
| Day High | $9.33 | P/E | N/A | |||
| Day Low | $9.33 | EPS | $0.00 | |||
| Volume | 7,352 | |||||
